Literature DB >> 24140644

Hepatocytes contribute to immune regulation in the liver by activation of the Notch signaling pathway in T cells.

Sven Burghardt1, Annette Erhardt, Benjamin Claass, Samuel Huber, Guido Adler, Thomas Jacobs, Athena Chalaris, Dirk Schmidt-Arras, Stefan Rose-John, Khalil Karimi, Gisa Tiegs.   

Abstract

The "liver tolerance effect" has been attributed to a unique potential of liver-resident nonprofessional APCs including hepatocytes (HCs) to suppress T cell responses. The exact molecular mechanism of T cell suppression by liver APCs is still largely unknown. In mice, IL-10-dependent T cell suppression is observed after Th1-mediated hepatitis induced by Con A. In this study, we show that HCs, particularly those from regenerating livers of Con A-pretreated mice, induced a regulatory phenotype in naive CD4(+) T cells in vitro. Using reporter mice, we observed that these T regulatory cells released substantial amounts of IL-10, produced IFN-γ, failed to express Foxp3, but suppressed proliferation of responder T cells upon restimulation with anti-CD3 mAb. Hence, these regulatory cells feature a similar phenotype as the recently described IL-10-producing Th1 cells, which are generated upon activation of Notch signaling. Indeed, inhibition of γ-secretase and a disintegrin and metalloproteinase 17 but not a disintegrin and metalloproteinase 10, respectively, which blocked Notch activation, prevented IL-10 secretion. HCs from Con A-pretreated mice showed enhanced expression of the Notch ligand Jagged1 and significantly increased receptor density of Notch1 on CD4(+) T cells. However, HCs from Con A-pretreated IFN regulatory factor 1(-/-) mice, which cannot respond to IFN-γ, as well as those from IFN-γ(-/-) mice failed to augment IL-10 production by CD4(+) T cells. In conclusion, it seems that HCs fine-tune liver inflammation by upregulation of Jagged1 and activation of Notch signaling in Th1 cells. This mechanism might be of particular importance in the regenerating liver subsequent to Th1-mediated hepatitis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24140644     DOI: 10.4049/jimmunol.1300826

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

Review 1.  Immune Tolerance for Autoimmune Disease and Cell Transplantation.

Authors:  Xunrong Luo; Stephen D Miller; Lonnie D Shea
Journal:  Annu Rev Biomed Eng       Date:  2016-02-24       Impact factor: 9.590

Review 2.  Immunology of hepatic diseases during pregnancy.

Authors:  Lars Bremer; Christoph Schramm; Gisa Tiegs
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

3.  DAP12 deficiency in liver allografts results in enhanced donor DC migration, augmented effector T cell responses and abrogation of transplant tolerance.

Authors:  O Yoshida; S Kimura; L Dou; B M Matta; S Yokota; M A Ross; D A Geller; A W Thomson
Journal:  Am J Transplant       Date:  2014-06-16       Impact factor: 8.086

4.  Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells.

Authors:  Mitchell Thorn; Gary R Point; Rachel A Burga; Cang T Nguyen; N Joseph Espat; Steven C Katz
Journal:  J Leukoc Biol       Date:  2014-08-01       Impact factor: 4.962

Review 5.  AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer.

Authors:  Helena Costa Verdera; Klaudia Kuranda; Federico Mingozzi
Journal:  Mol Ther       Date:  2020-01-10       Impact factor: 11.454

Review 6.  Maintaining T cell tolerance of alloantigens: Lessons from animal studies.

Authors:  Kortney A Robinson; William Orent; Joren C Madsen; Gilles Benichou
Journal:  Am J Transplant       Date:  2018-08       Impact factor: 8.086

7.  Graft-infiltrating PD-L1hi cross-dressed dendritic cells regulate antidonor T cell responses in mouse liver transplant tolerance.

Authors:  Yoshihiro Ono; Angelica Perez-Gutierrez; Toshimasa Nakao; Helong Dai; Geoffrey Camirand; Osamu Yoshida; Shinichiro Yokota; Donna Beer Stolz; Mark A Ross; Adrian E Morelli; David A Geller; Angus W Thomson
Journal:  Hepatology       Date:  2018-02-18       Impact factor: 17.425

Review 8.  Inflammatory processes in the liver: divergent roles in homeostasis and pathology.

Authors:  Ola Ahmed; Mark W Robinson; Cliona O'Farrelly
Journal:  Cell Mol Immunol       Date:  2021-04-16       Impact factor: 22.096

Review 9.  Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells.

Authors:  Andrea Kristina Horst; Katrin Neumann; Linda Diehl; Gisa Tiegs
Journal:  Cell Mol Immunol       Date:  2016-04-04       Impact factor: 11.530

10.  Superior Cervical Ganglia Neurons Induce Foxp3+ Regulatory T Cells via Calcitonin Gene-Related Peptide.

Authors:  Kirsten Szklany; Evelyn Ruiter; Firoz Mian; Wolfgang Kunze; John Bienenstock; Paul Forsythe; Khalil Karimi
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.